Introduction to Influenza Complications

The American Thoracic Society suggests that influenza can cause fever lasting 6 days, and this duration warrants careful evaluation for complications, particularly bacterial superinfection or pneumonia 1, 2, 3.

Expected Fever Duration and Complications

In uncomplicated influenza, the typical fever duration is 3-5 days, with antiviral treatment reducing symptom duration by approximately 24-36 hours, as recommended by the American Academy of Pediatrics 4, 5.
The hallmark of influenza is abrupt onset of fever (>38°C in adults, >38.5°C in children) along with cough, myalgias, and malaise, according to the British Thoracic Society 3.

The European Respiratory Society recommends evaluating for pneumonia by obtaining a chest X-ray if respiratory symptoms are prominent or the patient appears severely ill 6, 7.
Checking vital signs, including temperature, respiratory rate (>24/min concerning), heart rate (>100/min concerning), blood pressure, and oxygen saturation (<90% requires urgent intervention), is crucial, as suggested by the American College of Chest Physicians 1, 2, 6.
Assessing for bacterial superinfection, with the most common culprits being Staphylococcus aureus (including MRSA) and Streptococcus pneumoniae, is essential, according to the Infectious Diseases Society of America 3, 6.

Previously well adults with worsening symptoms (particularly recrudescent fever or increasing breathlessness) should be considered for antibiotic therapy, as recommended by the American Thoracic Society 1, 3.
First-line oral antibiotics, such as co-amoxiclav or doxycycline, should be used to cover both S. pneumoniae and S. aureus, according to the British Thoracic Society 3, 6, 7.
Antibiotics should be administered within 4 hours if pneumonia is confirmed on admission, as suggested by the American College of Emergency Physicians 1, 6.
Severely ill or hospitalized patients may still benefit from antiviral treatment started beyond 48 hours, according to the Centers for Disease Control and Prevention 1, 2, 6.

Age >65 years is automatically considered high-risk, and may present with atypical symptoms, including absence of fever, as noted by the American Geriatrics Society 7.
Chronic medical conditions, such as COPD, heart disease, diabetes, and immunosuppression, increase the risk of complications, according to the American Thoracic Society 3, 7.
Children <2 years are at higher risk of complications and hospitalization, as recommended by the American Academy of Pediatrics 4, 5.
Hospitalization should be considered if ≥2 of the following are present at day 6: temperature >37.8°C, heart rate >100/min, respiratory rate >24/min, systolic blood pressure <90 mmHg, oxygen saturation <90%, inability to maintain oral intake, or altered mental status, as suggested by the American College of Chest Physicians 1, 2, 6.

The Infectious Diseases Society of America recommends that treatment beyond 48 hours should still be offered to patients who are severely ill, hospitalized, or at high risk of complications, including those with chronic cardiac or pulmonary disease 8
The American Academy of Pediatrics notes that vomiting is the most common adverse effect of oseltamivir (15% vs 9% placebo), but it is typically mild and transient, especially when taken with food 9

The Infectious Diseases Society of America suggests that zanamivir (inhaled) or baloxavir (single oral dose) may be considered as alternatives to oseltamivir, though oseltamivir remains first-line due to oral administration and established efficacy 8, 9

The Infectious Diseases Society of America recommends that antibiotics are only indicated when bacterial superinfection is suspected, particularly with worsening symptoms after initial improvement, recrudescent fever, or increasing breathlessness, and first-line antibiotic choices include co-amoxiclav (amoxicillin-clavulanate), doxycycline, or cefuroxime to cover Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae 8